Moreover, a high expression of IL-7R on tumor cells was considered as a significant (p = 0.001) marker for poor overall survival, while a high expression of tumor interleukin 12 receptor β2 was associated with a better outcome (five-year recurrence-free probability; p = 0.026) for patients with stages IA and IB [38]. This evidence concerns the gene IL7R and neoplasm.